热景生物(688068.SH)子公司创新药SGT003注射液临床试验申请获批准

智通财经06-17

智通财经APP讯，热景生物(688068.SH)发布公告，近日，公司子公司北京舜景生物医药技术有限公司(简称“舜景医药”)收到国家药品监督管理局(NMPA)核准签发的《药物临床试验批准通知书》，舜景医药研制的创新药SGT003注射液临床试验申请(IND)已获得国家药品监督管理局(NMPA)批准。公告显示，SGT003注射液是一款基于舜景医药自主构建的NexTreg™技术平台开发的全球首款进入临床...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2644714731?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-17 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2644714731","market":"sh","top_or_hot":-1,"title":"热景生物(688068.SH)子公司创新药SGT003注射液临床试验申请获批准","media":"智通财经","content":"<div>\n<p>智通财经APP讯，热景生物(688068.SH)发布公告，近日，公司子公司北京舜景生物医药技术有限公司(简称“舜景医药”)收到国家药品监督管理局(NMPA)核准签发的《药物临床试验批准通知书》，舜景医药研制的创新药SGT003注射液临床试验申请(IND)已获得国家药品监督管理局(NMPA)批准。公告显示，SGT003注射液是一款基于舜景医药自主构建的NexTreg™技术平台开发的全球首款进入临床...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1455552.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>热景生物(688068.SH)子公司创新药SGT003注射液临床试验申请获批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n热景生物(688068.SH)子公司创新药SGT003注射液临床试验申请获批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-17 17:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1455552.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，热景生物(688068.SH)发布公告，近日，公司子公司北京舜景生物医药技术有限公司(简称“舜景医药”)收到国家药品监督管理局(NMPA)核准签发的《药物临床试验批准通知书》，舜景医药研制的创新药SGT003注射液临床试验申请(IND)已获得国家药品监督管理局(NMPA)批准。公告显示，SGT003注射液是一款基于舜景医药自主构建的NexTreg™技术平台开发的全球首款进入临床...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1455552.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688068","symbol_name":"热景生物","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1455552.html","article_id":"2644714731","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2644714731","pubTimestamp":1781687144,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，热景生物 发布公告，近日，公司子公司北京舜景生物医药技术有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，舜景医药研制的创新药SGT003注射液临床试验申请已获得国家药品监督管理局批准。公告显示，SGT003注射液是一款基于舜景医药自主构建的NexTreg技术平台开发的全球首款进入临床研究的新型双特异性抗体候选药物，其核心创新在于精准清除肿瘤微环境调节性T细胞，激活抗肿瘤免疫。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","688068":"热景生物","BK1161":"生物科技","BK1574":"生物医药B类股","BK0239":"医药制造","06978":"永泰生物-B"},"translate_title":"The clinical trial application of the innovative drug SGT003 injection of Rejing Biotech (688068.SH) subsidiary was approved","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1.5,"688068":1.5,"06978":1.5},"content_text":"智通财经APP讯，热景生物(688068.SH)发布公告，近日，公司子公司北京舜景生物医药技术有限公司(简称“舜景医药”)收到国家药品监督管理局(NMPA)核准签发的《药物临床试验批准通知书》，舜景医药研制的创新药SGT003注射液临床试验申请(IND)已获得国家药品监督管理局(NMPA)批准。公告显示，SGT003注射液是一款基于舜景医药自主构建的NexTreg™技术平台开发的全球首款进入临床研究(FIH)的新型双特异性抗体候选药物，其核心创新在于精准清除肿瘤微环境调节性T细胞(Tregs)，激活抗肿瘤免疫。该机制不仅能精准靶向肿瘤组织，调节肿瘤微环境，激活机体自身对肿瘤细胞的免疫应答，同时可以降低CTLA-4端免疫激活相关毒副作用，有效覆盖传统治疗耐药或无效的广泛实体瘤患者群体，有望成为肿瘤免疫治疗的基石用药。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2644714731","isCrawlerRequest":true}